Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

Ya Yuwen; Nan-nan Shi; Li-ying Wang; Yan-ming Xie; Xue-jie Han; Ai-ping Lu

doi:10.1007/s11655-012-0997-y

Your Location：

Home >

Browse articles >

Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

Updated：2021-08-27

- Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China
- Chinese Journal of Integrative Medicine Vol. 18, Issue 2, Pages: 112-119(2012)
- Affiliations：
  
  Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Supported by National Natural Science Foundation of China (No. 30825047), the Projects from State Administration of Traditional Chinese Medicine (No. ZYYS-2008), and China Academy of Chinese Medical Sciences (No. Z0135 and Z02128 and Z02114)
- DOI：10.1007/s11655-012-0997-y
  CLC：
- Published：2012，
  
  Published Online：5 February 2012，
Scan for full text
Yuwen, Y., Shi, Nn., Wang, Ly. et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China., Chin. J. Integr. Med. 18, 112–119 (2012). https://doi.org/10.1007/s11655-012-0997-y

Ya Yuwen, Nan-nan Shi, Li-ying Wang, et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China. [J]. Chinese Journal of Integrative Medicine 18(2):112-119(2012)
Yuwen, Y., Shi, Nn., Wang, Ly. et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China., Chin. J. Integr. Med. 18, 112–119 (2012). https://doi.org/10.1007/s11655-012-0997-y DOI：

Ya Yuwen, Nan-nan Shi, Li-ying Wang, et al. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China. [J]. Chinese Journal of Integrative Medicine 18(2):112-119(2012) DOI： 10.1007/s11655-012-0997-y.

摘要

To analyze the clinical practice guideline (CPG) development on 11 common diseases with Chinese medicine (CM) interventions in China. The CPGs of 11 common diseases which could be treated effectively with CM had been published between 1980 and 2010 in China. The 11 diseases include coronary heart disease (angina pectoris)

hypertension

chronic gastritis

rheumatoid arthritis

cerebral infarction

migraine

diabetes

primary osteoporosis

insomnia

common cold

and IgA nephropathy. The issuing organization

date of publication

development methods

and citation rate of the CPGs were analyzed. According to the development method

each guideline was categorized as consensus-based (CB)

evidence-based (EB)

or consensus based with no explicit consideration of evidence-based (CB-EB). Thirty-three CPGs on the 11 common diseases were found: 20 guidelines were classified as CB

13 as CB-EB and none as EB. Fifteen CPGs were issued by the China Association of Chinese Medicine

8 by professional working groups

and 4 by the State Administration of Traditional Chinese Medicine. Six guidelines were published between 1980 and 1990

9 between 1991 and 2000

and 18 between 2001 and 2010. Fifty-eight percent of these guidelines have not been amended timely. Only 54.5% (18/33) of the 33 guidelines were cited by other researchers and 45.5% (15/33) percent had never been cited. Most CPGs developed for 11 common diseases with CM approaches in China are consensus

and their citation rates are relatively low. The results suggest that more EB CPG or CPG strictly based on expert consensus could be developed

and great efforts should be made for future CM CPG application.

Abstract

hypertension

chronic gastritis

rheumatoid arthritis

cerebral infarction

migraine

diabetes

primary osteoporosis

insomnia

common cold

and IgA nephropathy. The issuing organization

date of publication

development methods

and citation rate of the CPGs were analyzed. According to the development method

each guideline was categorized as consensus-based (CB)

evidence-based (EB)

or consensus based with no explicit consideration of evidence-based (CB-EB). Thirty-three CPGs on the 11 common diseases were found: 20 guidelines were classified as CB

13 as CB-EB and none as EB. Fifteen CPGs were issued by the China Association of Chinese Medicine

8 by professional working groups

and 4 by the State Administration of Traditional Chinese Medicine. Six guidelines were published between 1980 and 1990

9 between 1991 and 2000

and their citation rates are relatively low. The results suggest that more EB CPG or CPG strictly based on expert consensus could be developed

and great efforts should be made for future CM CPG application.

关键词

clinical practice guidelinemethodologyChinese Medicine

Keywords

clinical practice guidelinemethodologyChinese Medicine

references

Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline developers handbook. http://www.sign.ac.uk/guidelines/fulltext/50.

Cruse H, Winiarek M, Marshburn J, Clark O, Djulbegovic B. Quality and methods of developing practice guidelines. BMC Health Serv Res 2002;2:1–7.

New Zealand Guidelines Group. Handbook for the preparation of explicit evidence-based clinical practice guidelines. New Zealand Guidelines Group 2001:1–157.

Association of Community Cancer Centers. Oncology patient management guidelines. Breast Carcinoma Version 3.0 ACCC 1999.

Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 8. Adjuvant systemic therapy for women with node-positive breast cancer. Can Med Assoc J 1998;158(3 Suppl):S52–S64.

Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network. Oncology (Williston park) 1999;13(5A):41–66.

National Research Symposium on Coronary Heart Disease Pattern Differentiation. Coronary heart disease syndrome differention standard for Chinese medicine. J Tradit Chin Med (Chin) 1980;21(8):46.

Stroke Council of Society of Internal Medicine, China Association of Chinese Medicine. Standard for diagnosis and efficacy evaluation of stroke with Chinese medicine. China J Tradit Chin Med Pharm (Chin) 1986;1(2):56.

Working Group of TCM Diagnostic Criterion for Disease Name. Standard for diagnosis of disease name with Chinese medicine. Changsha: Hunan Academy of Chinese medicine; 1987:1–661.

Society of Internal Medicine of China Association of Traditional Chinese Medicine. Standard for the diagnosis and efficacy evaluation of cardiac obstruction. China J Tradit Chin Med Pharm (Chin) 1988;3(2):66.

China Professional Committee of Chinese and Western Medicine with Digestive System. Standard for diagnosis, syndrome differention and efficacy of chronic gastritis with integrated traditional and Western medicine. Chin J Integr Tradit West Med (Chin) 1990;10:318–319.

Traditional Chinese Medicine & emergency Collaborative Group. Standard for diagnosis and treatment of emergency syndrome of thoracic obstruction heartache. State Administration Tradit Chin Med (Chin) 1990:64–74.

State Administration of Traditional Chinese Medicine. Standard for diagnosis and efficacy of Chinese medicine syndrome. Nanjing: Nanjing University Publishing House; 1994:1–326.

Collaborative Group of Cerebral Emergency Research of State Administration of Traditional Chinese Medicine. Standard for pattern differentiation of stroke (Trial). J Beijing Univ Tradit Chin Med (Chin) 1994;17(3):64–65.

Traditional Chinese Medicine & emergency Collaborative Group. Standard for diagnosis and treatment of Chinese medicine internal emergency. State Administration Tradit Chin Med (Chin) 1994:1–107.

Professional Committee of Rheumatism, China Association of Chinese Medicine. Standard for diagnosis and pattern differentiation of Wangbi. Conference Proceeding (Chin) 1996.

Collaborative Group of Cerebral Emergency of State Administration of Traditional Chinese Medicine. Standard for diagnosis and efficacy evaluation of stroke (Trial). J Beijing Univ Tradit Chin Med (Chin) 1996;19(1):55–56.

State Bureau of Technical Supervision. Clinical diagnosis and treatment terminology of Chinese medicine. Beijing: China Standard Press; 1997:1–103.

Collaborative Group of Emergency of State Administration of Traditional Chinese Medicine. Head wind disease syndrome diagnostic criteria. J Beijing Univ Tradit Chin Med (Chin) 1997;20(4):48–49.

IgA Nephropathy Collaboration Center of China Professional Committee for Nephropathy with Traditional Chinese Medicine. Standard for efficacy evaluation of IgA nephropathy. Conference Proceeding (Chin) 1998.

Osteoporosis Working Group of Osteoporosis Committee of China Association of Gerontology. Suggestion on diagnostic criteria of osteoporosis for Chinese (2nd ed). Chin J Osteoporos (Chin) 2000;6:1–3.

Shen SG, Wang CD, Yan XJ. Standard for diagnosis, efficacy and treatment of heart disease with Chinese medicine. Beijing: Beijing Publishing House of Science and Technology; 2002:1–179.

State Food and Drug Administration. Guiding principle of clinical researches on new drugs of traditional Chinese medicine. Beijing: China Medical Science and Technology Press; 2002:53–392.

Diabetes professional committee of China Association of Integrated Chinese and Western Medicine. Standard for diagnosis and therapeutic efficacy evaluation of diabetes mellius in integrative Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2005;25:94–95.

Expert Consensus Group of Definitions, Diagnosis and Treatment with Drugs of Insomnia. Guideline for definitions, diagnosis and treatment with drugs of insomnia (draft). Chin J Neurol (Chin) 2006;2:141–143.

Guideline Developing Group. A guideline for pre-clinical and clinical assessment on prevention and treatment of osteoporosis with traditional Chinese drugs. Beijing: People’s Medical Publishing House; 2006:1–77.

China Association of Chinese Medicine. Guidelines for Chinese medicine diabetes prevention and treatment. Beijing: China Press of Traditional Chinese Medicine; 2007:1–87.

Nephropathy Committee of China Association of Chinese Medicine. Standard for diagnosis, syndrome type and efficacy assessment of IgA nephropathy. Shanghai J Trad Chin Med (Chin) 2007;41(5):9–10.

China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine disease of modern medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:1–305.

China Association of Chinese Medicine. Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine symptoms in Chinese medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:1–147.

Song J, Chen KJ. Set clinical therapeutic guideline in traditional medicine urgently. Chin J Integr Tradit West Med (Chin) 2006;26:581–584.

Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992;268:240–248.

Mulrow CD. Systematic reviews: rationale for systematic reviews. BMJ 1994;309:597–599.

Field M, Lohr K. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: direction for a new program. Washington DC: National Academy Press; 1990:1–160.

Canadian Medical Association. Guidelines for Canadian clinical practice guidelines [2007-5-8]. http://mdm.ca/cpgsnew/cpgs/gccpg-e.htm.

Jin ZC. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. J Chin Integr Med (Chin) 2008;6:5–8.

Institute of Medicine. Guideline for clinical practice: from development to use. Washington DC: National Academic Press; 1992:1–241.

Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. http://www.agreecollaboration.iorg/instrument.

Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D. A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Intern J Quality Health Care 2005;17:235–242.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Big data is essential for further development of integrative medicine

Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Related Author

No data

Related Institution

Data Center of Chinese Medicine, China Academy of Chinese Medical Science

Institute of Clinical Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Chinese Medicine College, Ningxia Medical University

School of Chinese Medicine, Hong Kong Baptist University

Georg-August-Universität Göttingen, Göttingen

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰